A
$ Value
$0
Shares
151,351
Price
$0
Filed
Dec 8
Insider
Name
Lo Steven
Title
President, Chief Exec Officer
CIK
0001501959
Roles
Director
Officer
Transaction Details
Transaction Date
2025-12-04
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,841,712
Footnotes
Grant of shares upon vesting of restricted stock units, which fully vested on December 4, 2025. | This amount includes 57,723 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan. | Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 4, 2025.
Filing Info
Lo Steven's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-24 | VXRT | F | $87K |
| 2026-03-18 | VXRT | F | $14K |
| 2026-03-16 | VXRT | A | $0 |
| 2026-03-16 | VXRT | A | $0 |
| 2025-12-04 | VXRT | A | $0 |
| 2025-12-04 | VXRT | F | $20K |
| 2025-05-19 | VXRT | ▲ | $49K ★ |
Other Insiders at VXRT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lo Steven
President, Chief Exec Officer
|
— | — | 2026-03-24 |
|
Tucker Sean
SVP, Chief Scientific Officer
|
— | — | 2026-03-28 |
|
Cummings James F.
Chief Medical Officer
|
— | — | 2026-03-28 |
|
Berg Edward B
SVP, General Counsel
|
— | — | 2026-03-24 |
|
Grasman Jeroen Nicolaas
Chief Financial Officer
|
— | — | 2026-03-16 |